Search

Searching. Please wait…

Long-term efficacy and safety of risankizumab for active psoriatic arthritis: 148-week results from the KEEPsAKE 2 Trial

Other conference communications or articles related to authors from the University of Cantabria

 Congress: ACR Convergence (2023 : San Diego)

 Publisher: John Wiley and Sons Ltd

 Year of publication: 2023

 No. of pages: 4

 Publication type: Conference object

 ISSN: 2326-5205,2326-5191

Authorship

ÖSTÖR, ANDREW

DEN BOSCH, FILIP VAN

PAPP, KIM A.

ASNAL, CECILIA

AELION, JACOB

STAKIAS, VASSILIS

LYILE, THOMAS

CARTER, KYLE

SOLIMAN, AHMED

DROGARIS, LEONIDAS

CHEN, MICHAEL

PADILLA, BYRON

KIVITS, ALAN